Literature DB >> 9042524

Characterization of nitric oxide synthase isoforms expressed in different structures of the guinea pig cochlea.

K Gosepath1, I Gath, J Maurer, J S Pollock, R Amedee, U Förstermann, W Mann.   

Abstract

Nitric oxide synthase (NOS) activity and NADPH diaphorase staining has previously been reported in mammalian cochlea. Here we demonstrate immunoreactivity for neuronal-type NOS I and endothelial-type NOS III in the cochlea of the guinea pig. NOS I immunoreactivity was seen in inner and outer hair cells, and spiral ganglion cells. Staining for NOS I was also shown in basal and intermediate cells of the stria vascularis, spiral ligament cells, and the media of vessels near the modiolus. An antibody to NOS III stained primarily vascular endothelial cells. Some NOS III immunoreactivity was also detected in spiral ganglion cells. An antibody to the inducible-type NOS II did not stain any structure of the guinea pig cochlea, suggesting that this isoform is not expressed under physiological conditions. Nitric oxide produced by NOS I and/or NOS III may act as a neuromodulator in the organ of Corti and could also play a role as a regulator of cochlear blood flow.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9042524     DOI: 10.1016/s0006-8993(96)01149-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Evidence for a possible NOS back-up system in the organ of Corti of the guinea pig.

Authors:  Ulf-Rüdiger Heinrich; Jan Maurer; Wolf Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-22       Impact factor: 2.503

Review 2.  [Possible molecular mechanisms of spontaneous remission in sudden idiopathic hearing loss].

Authors:  U-R Heinrich; J Brieger; R H Stauber; W J Mann
Journal:  HNO       Date:  2011-11       Impact factor: 1.284

3.  Release and elementary mechanisms of nitric oxide in hair cells.

Authors:  Ping Lv; Adrian Rodriguez-Contreras; Hyo Jeong Kim; Jun Zhu; Dongguang Wei; Sihn Choong-Ryoul; Emily Eastwood; Karen Mu; Snezana Levic; Haitao Song; Petrov Y Yevgeniy; Peter J S Smith; Ebenezer N Yamoah
Journal:  J Neurophysiol       Date:  2010-03-10       Impact factor: 2.714

4.  Electron microscopic localization of nitric oxide I synthase in the organ of Corti of the guinea pig.

Authors:  U R Heinrich; J Maurer; K Gosepath; W Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

5.  Role of nitric oxide on purinergic signalling in the cochlea.

Authors:  Narinobu Harada
Journal:  Purinergic Signal       Date:  2010-06-08       Impact factor: 3.765

6.  Ischemia-reperfusion injury of the cochlea: pharmacological strategies for cochlear protection and implications of glutamate and reactive oxygen species.

Authors:  Keiji Tabuchi; Bungo Nishimura; Shuho Tanaka; Kentaro Hayashi; Yuki Hirose; Akira Hara
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

7.  Identification of novel cyclic nucleotide phosphodiesterase gene cDNAs in the cochlea of guinea pig (Cavia porcellus) through conserved homologous sequences.

Authors:  Min-Qi Huang; Jian-Guo Zhang; Yue-Sheng Long
Journal:  Mol Biotechnol       Date:  2009-08-26       Impact factor: 2.695

8.  [Attention diversion in tinnitus therapy. Comparison of the effects of different treatment methods].

Authors:  K Eysel-Gosepath; F Gerhards; K-H Schicketanz; K Teichmann; M Benthien
Journal:  HNO       Date:  2004-05       Impact factor: 1.284

9.  A dominant variant in the PDE1C gene is associated with nonsyndromic hearing loss.

Authors:  Li Wang; Yong Feng; Denise Yan; Litao Qin; M'hamed Grati; Rahul Mittal; Tao Li; Abhiraami Kannan Sundhari; Yalan Liu; Prem Chapagain; Susan H Blanton; Shixiu Liao; Xuezhong Liu
Journal:  Hum Genet       Date:  2018-06-02       Impact factor: 4.132

10.  Hyperbaric oxygen upregulates cochlear constitutive nitric oxide synthase.

Authors:  Chia-Der Lin; I-Hua Wei; Chih-Ho Lai; Te-Chun Hsia; Ming-Ching Kao; Ming-Hsui Tsai; Ching-Hsiang Wu; Mang-Hung Tsai
Journal:  BMC Neurosci       Date:  2011-02-22       Impact factor: 3.288

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.